Search
for
Sort by
Research 961–990 of 1000+
- Prostate cancer prevention
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- French administrative health care database (SNDS): The value of its enrichment
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Metabolic syndrome and skin: Psoriasis and beyond
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata
- Gefitinib: an adverse effects profile
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
- Treatment options for alopecia: an update, looking to the future
- Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers
- Disruption of tubular Flcn expression as a mouse model for renal tumor induction
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Successful treatment of female-pattern hair loss with spironolactone in a 9-year-old girl
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Hormonal manipulation of benign prostatic hyperplasia
- Cyproterone acetate as initial treatment and maintenance therapy for hirsutism
- Co-secretion of testosterone and cortisol by a functional adrenocortical oncocytoma
- Fibrotic enzymes modulate wound‐induced skin tumorigenesis
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Direct hair transplantation: A modified follicular unit extraction technique
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors